Ally Bridge Group (Ny) LLC Portfolio Holdings

Ally Bridge Group (Ny) LLC

  • $97 Million
  • Q3 2025

Ally Bridge Group (Ny) LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $97 Million distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Madrigal Pharmaceuticals, Inc. with a value of $15M, Atai Life Sciences N.V. with a value of $12.1M, Ascendis Pharma A/S with a value of $10.2M, Compass Pathways PLC with a value of $8.77M, and Taysha Gene Therapies, Inc. with a value of $5.98M.

Examining the 13F form we can see an increase of $27.4M in the current position value, from $69.6M to 97M.

Ally Bridge Group (Ny) LLC is based out at New York, NY

Below you can find more details about Ally Bridge Group (Ny) LLC portfolio as well as his latest detailed transactions.

Portfolio value $97 Million
Healthcare: $94.4 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$9.05B
$15 Million 15.44% of portfolio
32,662
Q3 2025 New
$664M
$12.1 Million 12.47% of portfolio
2,287,005
Q3 2025 New
$11.4B
$10.2 Million 10.47% of portfolio
51,080
Q3 2025 New
$363M
$8.77 Million 9.03% of portfolio
1,026,382
Q3 2025 Reduced 30.88%
$204M
$5.98 Million 6.16% of portfolio
1,898,112
Q3 2025 New
$743M
$5.94 Million 6.13% of portfolio
437,391
Q3 2025 New
$1.5B
$4.4 Million 4.53% of portfolio
233,220
Q3 2025 New
$1.92B
$4.21 Million 4.34% of portfolio
70,778
Q3 2025 Reduced 41.59%
$0
$2.62 Million 2.7% of portfolio
6,233,497
Q3 2025 Added 367.13%
$35.9M
$1.4 Million 1.44% of portfolio
817,939
Q4 2024 New
Monopar Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 86.63%
Lenz Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 48.92%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 69.16%
Solid Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 24.15%
Eupraxia Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 50.23%

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $97 Million
  • Prior Value $69.6 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 8 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email